GlassScriptPhysician profile
Danielle M Berglund
NPI 1710416052
$1,453.44
in general payments reported to CMS, 2019-2025
15 companies · $272 in 2025
The $272 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $57.33 · 2022: $491 · 2023: $284 · 2024: $349 · 2025: $272.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $483 · Food and Beverage: $422.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $483.43 |
| Food and Beverage | $422.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $262.24 | 2022-2025 | Jascayd |
| Sanofi-Aventis U.S. LLC | $231.93 | 2023-2025 | |
| Harmony Biosciences LLC | $211.47 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $103.66 | 2024-2025 | Dupixent |
| Genzyme Corporation | $100.00 | 2022-2023 | |
| Inspire Medical Systems, INC. | $94.24 | 2025 | Inspire |
| Astrazeneca Pharmaceuticals LP | $85.74 | 2022-2023 | Breztri |
| Philips North America LLC | $78.99 | 2022-2025 | Vest Therapy Und |
| Mylan Specialty L.P. | $77.11 | 2021-2022 | |
| Glaxosmithkline, LLC. | $75.15 | 2022-2023 | Nucala |
| Avadel Cns Pharmaceuticals, LLC | $49.27 | 2024 | Lumryz |
| Janssen Pharmaceuticals, INC | $34.60 | 2022 | |
| Baxter Healthcare | $19.21 | 2022 | |
| Insmed, INC. | $17.38 | 2025 | Brinsupri |
| Jazz Pharmaceuticals INC. | $12.45 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Berglund listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.